Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.510
-0.780-4.51%
Volume:8.50M
Turnover:140.91M
Market Cap:43.90B
PE:11.13
High:17.200
Open:17.200
Low:16.360
Close:17.290
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.49
T/O Rate:1.57%
Dividend:0.46
Dividend Rate:2.76%
EPS(LYR):1.483
ROE:6.95%
ROA:1.40%
PB:0.77
PE(LYR):11.13
PS:0.88

Loading ...

FOSUN PHARMA Subsidiary Starts Phase II Trial of Novel DPP-1 Inhibitor FXS7553 for COPD

Bulletin Express
·
Aug 13

Fosun Pharma Schedules 25 August 2026 Board Meeting to Approve 1H26 Results

Bulletin Express
·
Aug 13

Sinopharm Group Stock Slides 1.3% in Hong Kong

Dow Jones
·
Aug 11

Fosun Pharma Secures China Approval for Two Drugs

MT Newswires Live
·
Aug 10

Fosun Pharma Subsidiary Secures NMPA Approval for Dobutamine Hydrochloride Injection

Bulletin Express
·
Aug 07

Fosun Pharma Secures NMPA Green Light for Levosalbutamol Nebuliser Solution

Bulletin Express
·
Aug 07

Fosun Pharma Launches Head-to-Head Phase 3 Clinical Trial for a First-in-Class Drug

Deep News
·
Aug 07

Fosun Pharma's Dobutamine Hydrochloride Injection Receives NMPA Marketing Approval

Stock News
·
Aug 07

Shanghai Fosun Pharma - Drug Registration Application for Dobutamine Hydrochloride Injection Approved by Nmpa

THOMSON REUTERS
·
Aug 07

Sinopharm Group Stock Sheds 0.8% in Hong Kong

Dow Jones
·
Aug 07

FOSUN PHARMA Keeps Share Capital Unchanged in July 2026 Monthly Return

Bulletin Express
·
Aug 06

Fosun Pharma Units Get Registration Nod for Two Drugs in China

MT Newswires Live
·
Aug 03

Fosun Pharma Wins NMPA Nod for Empagliflozin–Metformin SR Tablets, Targeting China’s USD 674 Million Diabetes Market

Bulletin Express
·
Aug 03

Fosun Pharma Subsidiary Secures NMPA Green Light for Pediatric Constipation Treatment

Bulletin Express
·
Aug 03

Shanghai Fosun Pharma - Drug Registration Application for Empagliflozin & Metformin Hydrochloride Sustained-Release Tablets(Iii)Approved by Nmpa

THOMSON REUTERS
·
Aug 03

Shanghai Fosun Pharma - Registration Application for Polyethylene Glycol (3350) and Electrolytes Powder Approved by Nmpa

THOMSON REUTERS
·
Aug 03

Shanghai Fosun Pharmaceutical Secures Regulatory Approval for Diabetes Combination Drug

Stock News
·
Aug 03

Sinopharm Group Stock Falls 1.5% in Hong Kong

Dow Jones
·
Jul 31

Fosun Pharma's investment fund successfully completes registration with securities authorities

Stock News
·
Jul 29

Sinopharm Group Stock Climbs 2.6% in Hong Kong

Dow Jones
·
Jul 29